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Abstract
The overall aim of the 2014 Consultation is to bring together internal and external partners to help shape the
strategic direction for CAHRD over the 10 to 20 year horizon. Our strategic thinking will be guided by our vision of
a healthy future for low and middle income populations and our mission to transform health systems to improve
the health of these populations. Partnership between northern and southern institutions is integral to this work
and critical in the consultation process. The Consultation considers four selected areas of the current work of
CAHRD: Lung Health, Maternal & Newborn Health, Neglected Tropical Diseases, and Health Systems. We aim to
foster dialogue and learning between these and across contexts and disciplines. The major challenges that will
need to be addressed over the next 10 to 20 years will be scoped and pathways to possible solutions proposed.
The overall vision is a process of co-production of knowledge
Aim and objectives of the 2014 CAHRD
Consultation
The overarching Aim of the 2014 CAHRD Consultation
is to scope likely challenges on the 10 to 20 year hori-
zon for a selected range of health topics: Lung Health
(LH), Maternal & Newborn Health (MNH), Neglected
Tropical Disease (NTD), and Health Systems (HS) (see
Workstreams below), and to plan pathways towards
solutions for these challenges. This time scale was cho-
sen in recognition of the fact that research aimed at
providing new knowledge to overcome challenges and
bottle-necks in health improvement takes time to frame,
conduct, analyse, synthesise and use effectively in policy
and practice.
The specific Objectives of the 2014 Consultation are
to:
i. present concrete options for the further growth
and development of work within the selected
Workstreams
ii. identify cross-cutting themes and areas for colla-
boration across and between the Workstreams
iii. identify areas for collaboration between the 2014
Workstreams and other on-going Applied Health
Research & Delivery Activities
iv. strengthen existing collaborations and forge new
collaborations with global partners
The Workstreams of the 2014 Consultation were
selected from the full portfolio of Applied Health
Research & Delivery co-ordinated by LSTM as examples
of activity which:
i. represent a diverse range of health topics
ii. are from different places on the CAHRD spec-
trum of work (see Figs 3, 4, 5, 6)
iii. engage a diverse range of global partners
In addition, some of the selected Workstreams are
developing in collaboration with the methodological and
disciplinary expertise of the University of Warwick (for
examples: Mathematics & Epidemiology, Health Eco-
nomics, Management Sciences).Centre for Applied Health Research & Delivery, Liverpool School of TropicalMedicine, Pembroke Place, Liverpool L3 5QA
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As so many of the Applied Health Research & Deliv-
ery activities co-ordinated by LSTM fulfil all the criteria
above, the final selection of the 2014 Workstreams was
relatively arbitrary, with some bias towards areas which
have more recently become established. For this reason,
a brief overview of example areas of activity which were
not selected this year is included in this paper (see
Section 6 below)
Preparing for the 2014 CAHRD Consultation
Meeting: aiming for co-production of knowledge
Each Workstream was tasked with writing three discus-
sion papers, each scoping major challenges that will
need solutions over a 10 to 20 year time frame. Each
paper:
• is based on an area of work to which LSTM and
global partners have already made a contribution.
• includes a summary of the evidence to date –
where possible and appropriate includes reference to
available systematic reviews.
• is linked to an emerging international policy
agenda or strategy.
• outlines a strategic approach that the Collaboration
is well-placed to take forward.
Between February and May 2014, drafts of the 12 dis-
cussion papers have been shared for comment and edit-
ing across all Workstreams. This has provided an
internal and external review process and has promoted
dialogue across and between the Workstreams about
disciplinary approaches, contexts and health areas. It has
also permitted us to begin the identification of some
emerging cross-cutting themes and priorities (see
Section 7 below).
The papers have been circulated to the Consultation
participants as part of the ongoing process of facilitating
discussion within the meeting. They are not standalone,
finalised outputs in their own right, but rather a means
of eliciting perspectives from a relevant spectrum of
stakeholders as illustrated in Figure 1 and recently advo-
cated by Sheikh et al [1]. They are a starting point for
discussion.
The process of the 2014 CAHRD Consultation
Meeting: sequence of discussion and flow of
ideas and information
The overall sequencing of sessions and discussion is illu-
strated in Figure 2. The first day starts with brief presen-
tations of the discussion papers in plenary with some
initial commentary from selected members of the invited
external panel. This is followed by in-depth discussion in
groups which are reported back through sub-plenaries.
By the end of the first day each Workstream will have a
draft summary of progress and next steps ready for pre-
sentation back to the final plenary session at the end of
the following morning. Between those two steps there is
the opportunity to reflect and refine ideas in the light of
the content of the Leverhulme Lecture in the evening
of day one and a Question Time debate which opens
day two.
The Question Time debate gives the opportunity for
people who have not been able to attend the Consulta-
tion in person to contribute to the debate by having
their questions debated in public by an external panel.
Questions have been solicited in advance of the meeting
and will be posed to the Question Time panel. The
panel has been selected to be a mixture of senior,
experienced colleagues debating alongside younger
investigators. Not all panellists will be expected to
respond to all questions, and supplementary questions
can be asked from the floor. The intention is to provide
an opportunity for lively and open discussion to shed
additional perspectives on the topics of all four
Workstreams.
Applied Health Research & Delivery: Definitions
The domains of CAHRD activity include Applied
Health Research and Delivery, which we broadly define
as follows:
a) Applied Health Research. This encompasses the
activities that help develop practical solutions to health
needs and rights. It incorporates the spectrum of
research that delivers policy-relevant evidence and
includes operational, implementation, and health sys-
tems research. It is part of the value chain taking
knowledge from Discovery and Translation and mov-
ing it into policy and practice as illustrated below and
articulated in the recent literature [2]. These research
domains are required to develop and synthesise a
robust body of evidence to help drive policy and prac-
tice for health amongst poor and vulnerable popula-
tions in the developing world. It requires expertise
from a range of disciplines to combine and integrate
scientific, technological, economic and social insights.
Applied Health Research includes a strong focus on
taking interventions from regulatory approval through
to field implementation (See Figure 3)
b) Delivery. This encompasses all the activities that
develop individual and collective capabilities to
implement best practices in health service delivery
and multi-sectoral collaboration across a range of
health scenarios. It will, inter alia, use evidence gen-
erated through Applied Health Research to support
public health policy makers and providers in pro-
moting health practices and addressing the delivery
needs of poor populations, gender discrimination
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Figure 1 Co-production of knowledge (source: FutureEarth Research for Global Sustainability http://www.futureearth.info/who-we-are)
Figure 2 Overview of process for CAHRD Consultation programme
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and health inequities. Delivery is primarily about
supporting wide-scale implementation of interven-
tions that have strong evidence of effectiveness and
field-readiness (see Figure 4). It includes technical
assistance in the form of guidance to meet the speci-
fic needs of (e.g.) a Ministry of Health through colla-
borative communication between a specialist team
and the client.
Insights gained through health Delivery work clearly
inform further Applied Health Research (See Figure 5):
The bi-directional flow of knowledge in relation to
Applied Health Research has been represented in a lin-
ear fashion (see above). It is recognised, however, that in
practice, multiple feedback loops operate in the many
cycles of generating innovation, evidence and implemen-
tation. It is important to recognise that CAHRD fosters
these feedback loops and maintains close and productive
linkages with other domains of work, including Discov-
ery and Translational Research.
The four Workstreams (Lung Health, Maternal &
Newborn Health, Neglected Tropical Diseases, &
Health Systems) selected for the 2014 CAHRD
Consultation
The four Workstreams were selected to represent a
diversity of health topics where linkages into broad
health systems work are being developed or are ongoing.
The vision is that by focussing on these areas as exam-
ples, learning points for other areas could also be eli-
cited. Inevitably a number of key areas of on-going work
(see below) could not be covered in this first Consulta-
tion. There will be opportunities to focus on these in
future Consultations. The precise placement of the
Workstreams on the spectrum described above is diffi-
cult, as many encompass a considerable breadth of
activity. Illustrative placements are depicted according
to their main “centre of gravity” in Figure 6. Brief
descriptions of each Workstream and some reasons for
their selection then follow. Surnames of Workstreams
leaders are included.
a) Lung Health is an area where experience in
chronic infectious disease control (mainly TB & HIV)
provides a starting point for approaching chronic
non-communicable disease control (Mortimer, et al)
Consensus is building around the need for a greater
focus on combating Non-Communicable Diseases
(NCDs) such as diabetes, heart disease, chronic obstruc-
tive pulmonary disease (COPD) and asthma. These
chronic illnesses require life-long clinical and public
health management and are projected to contribute an
increasing proportion of the global burden of disease in
the next 10 to 20 years. LSTM and partners have
attracted a number of staff interested in promoting
improved prevention and management of chronic air-
ways disease (COPD and asthma) in developing coun-
tries. With chronic cough as the commonest presenting
symptom of TB, and a common feature of COPD
(chronic bronchitis phenotype), asthma and bronchiecta-
sis, there is an increasing need for health services to
provide diagnostic and clinical management plans for
these patients. These need to work in synergy with
multi-sectoral development and evaluation of preventive
strategies such as reduction of indoor air pollution and
tobacco control.
b) Maternal and Newborn Health remains in the
spotlight (Van den Broek et al)
The need to reduce maternal and child mortality and
morbidity has been the subject of extensive high level
discussion. In part this is driven by clarity that the
reductions in mother and child mortality demanded by
the Millennium Development Goals (MDGs), even
though on track, will not be met by most countries by
2015. Major global health funders have signalled that
maternal and child health programmes will remain
among their highest priorities. The latest maternal glo-
bal mortality figures were released in May 2014 and
illustrate the need for accelerated action. Within child
health, the main focus will be on the newborn with new
targets and actions agreed to reduce neonatal deaths
and stillbirths.
Figure 3 Defining Applied Health Research
Figure 4 Defining Delivery
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LSTM’s Centre for Maternal & Newborn Health man-
ages a large portfolio of work focussed on design, imple-
mentation and evaluation of interventions to improve
availability and quality of care for mothers and babies in
low and middle income countries.
c) Neglected Tropical Diseases are nearing a period
of transition in approaches needed for control (Torr
et al)
Huge gains have been made in the control of NTD’s
through the use of preventive chemotherapy in mass drug
administration (MDA) programmes. These programmes
have largely been delivered with a “vertical” approach and
with specific diseases targets such as schistosomiasis, lym-
phatic filariasis and onchocerciasis. With the success of
these programmes, some countries now face a future in
which disease prevalence will fall and control will rely
increasingly on interventions delivered through a more
integrated approach within routine health services. Some
countries, however, have only just started MDA pro-
grammes. These tend to be fragile or conflict affected
states and success may not come so easily in these more
challenging contexts. In addition there is an increasing
recognition that some of the NTDs (e.g. trypanosomiasis)
are not amenable to mass drug administration approaches,
and will require multi-sectoral engagement including
health, agriculture and veterinary services. LSTM has sup-
ported the science behind mass drug administration for
NTDs over many years. There has also been substantial
work at LSTM developing new diagnostics, drugs and
insecticides for the control of NTD’s. Many of these will
be transitioning into field use in the next 10 to 20 years.
These need to be evaluated in large scale population based
studies in relevant disease endemic country settings.
Evaluations will require health economic, logistics, delivery
and social science inputs.
d) Strengthened Health System approaches will be
critical for delivery of health improvements in all dis-
ease-specific areas (Theobald, MacPherson, Raven,
Tolhurst et al)
Formal health systems serving poor populations in the
developing world tend to be weak in components of govern-
ance, human resources, financing, essential
Figure 5 Applied Health Research and Delivery informing each other
Figure 6 The four Workstreams (Lung Health, Maternal & Newborn Health, Neglected Tropical Diseases, & Health Systems) in relation to the
spectrum of Applied Health Research & Delivery.
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technologies, and health information systems. Human
resources are absolutely critical for improvements in
health. With severe shortages of formally trained and
skilled staff in all of the disease-specific areas described
above, there has been a growing experience with the
use of close-to-community providers or community
health workers. Human resource constraints are parti-
cularly limiting in fragile, post-conflict states, where
disease burdens are also high. In order to overcome
these and other health system constraints, effective
approaches to both individual and systems capacity
strengthening are required.
Examples of on-going activities co-ordinated by
LSTM but not the focus of the 2014 Consultation
Inevitably, a number of key areas of on-going work could
not be covered in the 1.5 days of this first CAHRD Con-
sultation. However, one objective of the Consultation is
to identify potential synergies between these activities
and the Workstreams, and the intention is to return to
these in future Consultations. As in Section 5 above, the
precise placement of existing research groups and con-
sortia on the spectrum of Applied Health Research &
Delivery is difficult. Illustrative placements are depicted
according to their main “centre of gravity” in Figure 7.
Brief descriptions of selected areas of work then follow
along with surnames of key investigators.
a) Evidence Synthesis (Garner et al)
Systematic reviews are central to translating research
into policy and practice. LSTM has hosted the Cochrane
Infectious Disease Group since 1996. The group consists
of 17 editors and has published 144 reviews. It has made
several contributions to policy development. Selected
examples include a global change in the formula for oral
rehydration salt; [3] the move from monotherapy to arte-
sunate combination chemotherapy for malaria; [4] debate
about the benefits of deworming for child health; [5] and
the decentralisation of HIV treatment from hospitals to
health centres [6].
b) METRe - development of innovative tools for
monitoring of health programmes (Valadez et al)
The multi-disciplinary METRe Group was created to
provide technical assistance and build capacity in low
resource countries on how to effectively collect, analyse
and use quality data to guide decision making for health
programmes and policies. The group’s main scope of
work includes the development of innovative tools for
monitoring of health programmes, such as using Lot
Quality Assurance Sampling (LQAS) to provide real-
time district level health information at both the house-
hold and health facility level [7-9].
The group specialises in the development and use of
practical tools for assessment [10]. METRe is committed
to developing local capacity to undertake this work, and
uses a Learning By Doing approach for this purpose [11].
Research is an on-going component of the work of the
METRe group which strives to ensure that monitoring
strategies are evidence-based. Recent projects include:
• An evaluation of the effect of a results-based finan-
cing (RBF) intervention in Acholi region, Northern
Uganda for DfID.
• Support to the government of South Sudan to
strengthen systems for collecting health data using a
mixture of Health Facility Surveys (HFS) commu-
nity-based Household Surveys (HHS) and strength-
ening of HMIS data collection procedures.
• Support to the National Vector Borne Disease
Control Program by working in 21 districts in Odi-
sha State, India.
c) Malaria (Hemingway, Ranson, ter Kuile, et al)
The malaria research and delivery activities of LSTM
have been aimed at improving control in high risk
Figure 7 Examples of on-going activities co-ordinated by LSTM across the spectrum and in relation to Discovery, Translation, Evidence Synthesis
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populations such as infants, young children, HIV-
infected people. Both vector control and treatment
approaches have been employed.
Malaria in pregnancy (MiP) can have devastating con-
sequences in both mother and fetus. The MiP Consor-
tium was initiated with funding from the Bill & Melinda
Gates Foundation in 2008 and coordinated by a secretar-
iat based at LSTM. It has provided key contributions to
WHO’s new global burden of MiP estimates [12]) and
helped WHO and countries achieve a better understand-
ing of the coverage and reasons behind the low uptake of
existing interventions by pregnant women of existing
interventions [13-15]. Through this work it provided the
evidence that led WHO in 2013 to update its policy
recommendation for the prevention of MiP, benefiting
39 countries in sub-Saharan Africa [16]. In June 2015 at
WHO’s Evidence Review Group on MiP the Consortium
will present results of 4 multi-country prevention trials
potentially leading to further policy change.
More recently the emphasis has shifted from research in
high risk populations to a focus on reduction of malaria
transmission. This will involve applied health research that
is closely linked to programme implementation.
d) Tuberculosis Control (Cuevas, Squire, Theobald et al)
Tuberculosis is still one of the main causes of adult
death in the world. The tools for prevention, diagnosis
and treatment are still inadequate and health systems
face enormous bottlenecks that hinder its control.
LSTM’s TB research focuses on generating key evidence
to improve the smear-diagnosis of patients attending
microscopy centers in resource poor settings, which
contributed to several WHO policy changes in recent
years including a reduction in the recommended num-
ber and collection sequence for collection of sputum
specimens [17].
It is acknowledged that one third of the TB cases occur-
ring each year are not reported by National Programmes
and that limited access to diagnosis is a key contributor,
often with catastrophic economic costs for the patient, the
family and the economy. Modelling work developed by
LSTM has highlighted that new diagnostics would have
limited impact if these tools are not implemented within
systems that increase their accessibility to the place of need
[18,19]. We demonstrated that approaches that are closer
to the community than stationary health services can dra-
matically increase access to diagnosis and treatment of dis-
advantage populations [20,21]. LSTM work focusing in
close to community approaches for TB has been high-
lighted as a trail-finder by the World Bank and the Global
Fund and was presented at the World Health Assembly as
means of increasing service access for women.
e) Adolescent Sexual Health (Obasi et al)
Improving adolescent reproductive health (ARH) in
LMIC is key to their development. Pregnancy related
death is the single biggest cause of death amongst girls
aged 15-19 [22] and rates of sexually transmitted infec-
tions (STI) are at their peak among adolescents and
young adults. However, the cultural, social and biologi-
cal drivers of reproductive ill health in this age group
are complex. Applied research is critical to understand-
ing and addressing this complexity, as demonstrated by
the LSTM-led evaluation of the scale-up of the Mema
kwa Vijana (MkV) multicomponent ARH intervention
in Tanzania (MkV2) [23].
The MkV intervention [23] informed the development
of Government of Tanzania Youth Friendly Services
guidelines and was adopted by WHO as a best practice
intervention [24]. The MkV2 programme evaluated a 10
fold scale-up of the MkV intervention through existing
government health and education systems. In addition to
evaluation of the process of implementation, this
research uniquely examined the local government policy
process related to scale up and informed the 2013
UNESCO consultation on sexuality education [26,26-28].
The implementation research in MkV2 highlighted the
need and potential strategies for better integration
between intervention settings, which is the focus of
research led by LSTM through the IntHEC EU-funded
consortium and illustrates how Delivery feeds back to
Applied Research (Fig 5 above). Outputs from this
research range from the first description of the repro-
ductive outcomes and practices of very young adolescent
girls (aged 11-15) in Niger, to an evaluation of mobile
phone technology as a means of improving the integra-
tion of close to community providers in reproductive
health service provision in Tanzania.
f) HIV Testing & Counselling (Taegtmeyer et al)
There is increasing evidence for the importance of
anti-retroviral therapy in both improving the health of
HIV-infected individuals and preventing new infections
[29]. With large ‘testing gaps’ remaining in countries
with high HIV prevalence, policy makers urgently need
evidence on the models and approaches to the scale-up
of HIV Testing & Counselling (HTC) [30]. LSTM has
spearheaded HTC scale-up through combining applied
health research with policy influence and partnership
with governments and NGOs that deliver these services.
It has demonstrated effective quality assurance systems
for HTC scale up in Kenya, co-authored a number of
WHO documents on quality and developed an interna-
tional practical manual on home-based HTC [31]. In
April 2013 LSTM organized and co-hosted the First
International Symposium on the legal, ethical, gender,
human rights and public health aspects of HIV self-testing
[32] and is working on a range of studies to address
research gaps in this area, including on target product pro-
files of diagnostics, on couples testing, on the potential for
social harms and on the uptake of counselling.
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All of the above areas of work remain priorities for
LSTM and will be carried forward in synergy with the
outcomes of the 2014 CAHRD Consultation.
Emerging outcomes of the Consultation
Bearing in mind the overall Aim to plan pathways
towards solutions for challenges on the 10 to 20 year
horizon, the following are initial reflections on progress
towards the Objectives. At this stage these are very
much in draft form and outlined here to stimulate
further discussion, refinement and change in the course
of the work on 12th & 13th June.
a) Presenting concrete options for the further
growth and development of work within the selected
Workstreams.
b) Identifying cross-cutting themes and areas for
collaboration across and between the Workstreams
At this stage, the following cross-cutting themes are
emerging from the discussion papers and present oppor-
tunities for closer collaboration and sharing of experi-
ence and expertise between the four Workstreams:
i. Equity impact (including poverty status, gender,
and intra-household dynamics) on access to health-
care, and the pivotal roles of focusing on human
resources for health (in the broadest sense: CTC,
capacity strengthening, & approaches to human
resource management) in promoting equity in
access. The importance of improving the measure-
ment and understanding of costs to patients of
healthcare utilization in relation to income.
ii. Devising sustainable approaches to health service
provision for chronic ill-health and disability will
be a major challenge in the 10-20 year horizon.
Table 1. Summary of options for further growth and development of work within the four Workstreams
Lung Health i. Work towards better understanding of the health risks associated with Household Air Pollution (HAP), and what
level of reduction of HAP is necessary to improve health.
ii. Better evidence on which interventions for reducing household air pollution (technologies [e.g. stoves], fuels,
ventilation, behaviour) are most effective at reducing HAP.
iii. Community burden of chronic respiratory diseases in relation to epidemiological and socio-economic factors
iv. Developing and testing health system diagnostic and clinical management pathways for patients with chronic
cough, including provision for acute episodes
v. Studies and systematic reviews of patient costs associated with chronic non-communicable respiratory disease
vi. Work towards deeper understanding and effective measurement of catastrophic care-seeking costs
Maternal & Newborn
Health (MNH)
i. The validity of MNH as a ‘litmus test’ for Universal Health Coverage (UHC)
ii. Design and implementation of a single essential minimum health care package for mothers and babies, including
understanding whether such package should include (e.g.) more gynaecological care, cancer screening & mental
health
iii. Models for the uptake, establishment and maintenance of audits of maternal deaths and stillbirths to improve
quality of care, including new classification systems for attribution of cause of death and factors associated with
death
iv. Better understanding of the term “operations research” and more use of operations research in design and
implementation of care packages to improve MNH
Neglected Tropical
Diseases (NTD)
i. A new suite of tools and approaches for: sensitive surveillance of NTD transmission, decision support technology to
facilitate effective responses to surveillance data, reduction of transmission (both vector control and chemotherapy of
infected individuals)
ii. New, better integrated health systems and transmission models for local decision making in policy and practice,
along with capacity to develop and use these models.
iii. Developing packages of care for the management of disability and promotion of mental health for those who live
with chronic disabling and disfiguring consequences of NTD.
iv. Identifying and controlling disease in hard-to-reach foci, along with maintaining momentum
Health Systems i. Identifying best approaches to motivate, retain, and support different types of female and male close to
community (CTC) providers as a key part of progress towards UHC
ii. Working on opportunities for CTC providers to better address gendered social determinants of health at
community level, and to promote effective multi-sectoral engagement
iii. Developing human resource management systems, promoting health workforce supply, and improving health
workforce performance in fragile and conflict-affected states (FCAS)
iv. Wider use of a systematic, evidence-based approach for designing health research capacity strengthening (RCS)
programmes, including implementation of common frameworks and use of monitoring indicators to capture impact
on health systems and outcomes
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While this need is increasingly articulated for the
non-communicable diseases, there is a less recognised
need emerging for the management of the chronic
effects of all diseases in terms of disability and mor-
bidity such as those associated with the NTD’s.
iii. the need for multi-sector interventions to tackle
the broad determinants of health leads to the obser-
vation that there are very few models of effective
multi-sector engagement.
iv. The need for new and intensive multi-disciplinary
approaches in applied health research and delivery,
including a focus on capacity strengthening as a criti-
cal bottleneck between research and improved health.
v. Delivering sustainable, affordable, healthcare and
disease prevention programmes really close to
communities.
vi. Developing health systems in conflict affected
and fragile states and marginalized populations.
vii. The need for new tools, applied research methods,
locally tailored modelling approaches, technologies
and strategies in the areas of diagnostics, treatment,
health system functioning, and information systems.
These emerging themes resonate to differing extents
with the Workstreams and Discussion papers as illu-
strated in Figure 8.
c) Identifying areas for collaboration between the
2014 Workstreams and existing Applied Health
Research & Delivery Activities
Initial intersections between existing Applied Health
Research & Delivery topics and the four Workstreams
have been mapped in Figure 9.
Figure 8 Cross-cutting themes in relation to Workstreams and Discussion Papers
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d) Strengthening existing collaborations and for-
ging new collaborations with global partners
Awaits results of further discussion on 12th & 13th June
Taking forward the strategic direction
A number of processes are suggested to help take for-
ward the ideas and plans from the Consultation:
a) Evidence Synthesis. Some questions emerging
from the discussion papers could benefit from more
formal systematic reviews. For example the work on
catastrophic costs calls for a systematic review of
studies of patients costs incurred during care-seeking
for chronic respiratory diseases.
b) Focussed Discussion Workshops. Some of the
options are likely to need further work after the Consul-
tation. Individuals working in the Consultation Work-
streams and individuals working on existing activities
and those interesting in exploring more work on the
cross-cutting themes could consider this option.
c) Grant writing panels. Some areas of activity
could be matched to existing funding schemes and
taken forward in the short term.
d) Publications. Some of the discussion papers
could be further developed for publication. Examples
include the work of the BREATHE Consortium in
putting together a series for the Lancet Respiratory
Medicine.
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